BMY
Bristol-Myers Squibb
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: BMY
- PE Ratio
As of Jul 31, 2026, the Bristol-Myers Squibb stock's P/E ratio is 14.35. This takes into account the latest EPS of $4.55 and stock price of $65.31. The PE ratio has decreased by 4.9% from its last 4 quarters average of 15.1.
BMY PE ratio history
The PE ratio of Bristol-Myers Squibb has averaged 35.84 over the last ten years. The current price-to-earnings ratio of 14.35 is 60% less than the historical average. Analyzing the last ten years, BMY's PE ratio reached its highest point in the Jun 2018 quarter at 221.36, when the price was $55.34 and the EPS was $0.25. The lowest point was recorded in the Jun 2019 quarter, when it reached 11.93 with a price of $45.35 and an EPS of $3.8.
Bristol-Myers Squibb PE ratio by year
Maximum annual increase: 358.93% in 2017
Maximum annual decrease: -82.81% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 15.54 | N/A | $53.94 | $3.47 |
| 2024 | N/A | N/A | $56.56 | -$4.41 |
| 2023 | 13.22 | -45.44% | $51.31 | $3.88 |
| 2022 | 24.23 | 22.44% | $71.95 | $2.97 |
| 2021 | 19.79 | N/A | $62.35 | $3.15 |
| 2020 | N/A | N/A | $62.03 | -$3.99 |
| 2019 | 31.78 | 84.02% | $64.19 | $2.02 |
| 2018 | 17.27 | -82.81% | $51.98 | $3.01 |
| 2017 | 100.46 | 358.93% | $61.28 | $0.61 |
| 2016 | 21.89 | -70.09% | $58.44 | $2.67 |
| 2015 | 73.18 | 49.99% | $68.79 | $0.94 |
| 2014 | 48.79 | 43.21% | $59.03 | $1.21 |
| 2013 | 34.07 | 22.33% | $53.15 | $1.56 |
| 2012 | 27.85 | 72.23% | $32.59 | $1.17 |
| 2011 | 16.17 | 9.93% | $35.24 | $2.18 |
Bristol-Myers Squibb PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 12.66 | -25.49% | $57.62 | $4.55 |
| Mar 2026 | 16.99 | 9.33% | $60.65 | $3.57 |
| Dec 2025 | 15.54 | 2.3% | $53.94 | $3.47 |
| Sep 2025 | 15.19 | -18.29% | $45.1 | $2.97 |
| Jun 2025 | 18.59 | -18.32% | $46.29 | $2.49 |
| Mar 2025 | 22.76 | N/A | $60.99 | $2.68 |
| Dec 2024 | N/A | N/A | $56.56 | -$4.41 |
| Sep 2024 | N/A | N/A | $51.74 | -$3.59 |
| Jun 2024 | N/A | N/A | $41.53 | -$3.25 |
| Mar 2024 | N/A | N/A | $54.23 | -$3.09 |
| Dec 2023 | 13.22 | -9.58% | $51.31 | $3.88 |
| Sep 2023 | 14.62 | -13.59% | $58.04 | $3.97 |
| Jun 2023 | 16.92 | -15.53% | $63.95 | $3.78 |
| Mar 2023 | 20.03 | -17.33% | $69.31 | $3.46 |
| Dec 2022 | 24.23 | 5.3% | $71.95 | $2.97 |
BMY Price vs fair value
BMY average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of BMY is under its 3, 5 and 10-year averages.
PE comparison
With a price to earnings (P/E) of 14.35, BMY stands lower than the Healthcare sector, the industry and its peers average. Looking at the Healthcare sector average of 26.04, Bristol-Myers Squibb's price to earnings (P/E) is 45% lower.
BMY PE vs peers
BMY's PE ratio is below its peer stocks LLY and JNJ. Bristol-Myers Squibb's current PE ratio of 14.35 is less than the average of its peers, which is 29.37.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BMY Bristol-Myers Squibb Company | 14.65 | $136.19B |
| PFE Pfizer Inc | 19.32 | $144.22B |
| AZN Astrazeneca plc | 23.24 | $242.81B |
| NVS Novartis AG | 23.34 | $295.43B |
| AMGN AMGEN Inc | 26.74 | $208.99B |
| JNJ Johnson & Johnson | 29.14 | $612.99B |
| ABT Abbott Laboratories | 35.18 | $188.7B |
| MRK Merck & Co Inc | 36.4 | $320.93B |
| LLY Lilly(Eli) & Company | 40.5 | $1.08T |
| ABBV Abbvie Inc | 123.78 | $443.96B |
Frequently asked questions
What is Bristol-Myers Squibb's PE ratio?
As of Jul 31, 2026, BMY stock has a price to earnings ratio of 14.35.
What is the 3-year average PE ratio for Bristol-Myers Squibb (BMY)?
The 3-year average PE ratio for BMY stock is 16.2.
What is the 5-year average PE ratio for Bristol-Myers Squibb (BMY)?
The 5-year average PE ratio for BMY stock is 18.97.
What is the highest PE ratio for BMY?
Over the last ten years, the quarterly PE ratio reached its highest level at 221.36 in the Jun 2018 quarter.
How does the current PE ratio for BMY compare to its historical average?
BMY's price to earnings ratio is currently 60% below its 10-year historical average.
How is BMY's PE ratio calculated (Bristol-Myers Squibb PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jul 31, 2026), Bristol-Myers Squibb's share price is $65.31. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $4.55. Therefore, Bristol-Myers Squibb's price to earnings ratio for today is 14.35. PE RATIO(14.35) = STOCK PRICE($65.31) / TTM EPS($4.55)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.